Skip to main content
Top
Published in: Tumor Biology 5/2014

01-05-2014 | Research Article

Association of single nucleotide polymorphisms of nucleotide excision repair genes with laryngeal cancer risk and interaction with cigarette smoking and alcohol drinking

Authors: Xiaoyu Li, Jing Xu, Xinxin Yang, Yungang Wu, Baohua Cheng, Dongfeng Chen, Bo Bai

Published in: Tumor Biology | Issue 5/2014

Login to get access

Abstract

We investigated the potential association of 12 single nucleotide polymorphisms (SNPs) of nucleotide excision repair (NER) genes with risk of laryngeal cancer. A ratio of 1:1 matched case–control study was conducted. Conditional regression analysis indicated that subjects with ERCC1 rs11615 CC and C allele had an increased risk of laryngeal cancer compared with the TT genotype. Individuals with the ERCC5 rs17655 GG and G allele had a moderately increased risk of laryngeal cancer when compared with the CC genotype. By stratified analysis, ERCC1 rs11615 CC genotype and C allele were significantly associated with greatly increased risk of laryngeal cancer in ever smokers. ERCC1 rs11615 and ERCC5 rs17655 polymorphisms were associated with a moderately increased risk of this cancer in ever drinkers. In summary, we suggest that genetic variations in ERCC1 rs11615 and ERCC5 rs17655 are associated with laryngeal cancer risk in a Chinese population, especially in ever smokers and drinkers. Our finding could be helpful in identifying people at high risk for the disease for early intervention.
Literature
2.
go back to reference Zhuo WL, Wang Y, Zhuo XL, Zhu B, Zhu Y, Chen ZT. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. J Cancer Res Clin Oncol. 2009;135:1081–90.CrossRefPubMed Zhuo WL, Wang Y, Zhuo XL, Zhu B, Zhu Y, Chen ZT. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. J Cancer Res Clin Oncol. 2009;135:1081–90.CrossRefPubMed
3.
go back to reference Vassileiou A, Vlastarakos PV, Kandiloros D, Delicha E, Ferekidis E, Tzagaroulakis A, et al. Laryngeal cancer: smoking is not the only risk factor. B-ENT. 2012;8(4):273–8.PubMed Vassileiou A, Vlastarakos PV, Kandiloros D, Delicha E, Ferekidis E, Tzagaroulakis A, et al. Laryngeal cancer: smoking is not the only risk factor. B-ENT. 2012;8(4):273–8.PubMed
4.
go back to reference Wang J, Gao J, Li Y, Zhao X, Gao W, Peng L, et al. Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Gene. 2013;524(2):193–6.CrossRefPubMed Wang J, Gao J, Li Y, Zhao X, Gao W, Peng L, et al. Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Gene. 2013;524(2):193–6.CrossRefPubMed
5.
go back to reference Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study. Cancer Causes Control. 2002;13(10):957–64.CrossRefPubMed Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case–control study. Cancer Causes Control. 2002;13(10):957–64.CrossRefPubMed
6.
go back to reference Helleday T, Lo J, van Gent DC, Engelward BP. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst). 2007;6(7):923–35.CrossRef Helleday T, Lo J, van Gent DC, Engelward BP. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst). 2007;6(7):923–35.CrossRef
7.
go back to reference Longhese MP, Mantiero D, Clerici M. The cellular response to chromosome breakage. Mol Microbiol. 2006;60(5):1099–108.CrossRefPubMed Longhese MP, Mantiero D, Clerici M. The cellular response to chromosome breakage. Mol Microbiol. 2006;60(5):1099–108.CrossRefPubMed
8.
go back to reference Romanowicz-Makowska H, Smolarz B, Gajęcka M, Kiwerska K, Rydzanicz M, Kaczmarczyk D, et al. Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci. 2012;8(6):1065–75.CrossRefPubMedPubMedCentral Romanowicz-Makowska H, Smolarz B, Gajęcka M, Kiwerska K, Rydzanicz M, Kaczmarczyk D, et al. Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci. 2012;8(6):1065–75.CrossRefPubMedPubMedCentral
9.
go back to reference Sliwinski T, Walczak A, Przybylowska K, Rusin P, Pietruszewska W, Zielinska-Blizniewska H, et al. Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Exp Mol Pathol. 2010;89(3):358–66.CrossRefPubMed Sliwinski T, Walczak A, Przybylowska K, Rusin P, Pietruszewska W, Zielinska-Blizniewska H, et al. Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Exp Mol Pathol. 2010;89(3):358–66.CrossRefPubMed
10.
go back to reference Weber A, Tannapfel A, Wittekind C, Bootz F. Carcinogen-induced site-specific mutagenesis and genetic susceptibility in squamous cell carcinoma of the head and neck. Onkologie. 2002;25(1):8–13.PubMed Weber A, Tannapfel A, Wittekind C, Bootz F. Carcinogen-induced site-specific mutagenesis and genetic susceptibility in squamous cell carcinoma of the head and neck. Onkologie. 2002;25(1):8–13.PubMed
11.
12.
go back to reference Sliwinski T, Markiewicz L, Rusin P, Kabzinski J, Dziki L, Milonski J, et al. Impaired nucleotide excision repair pathway as a possible factor in pathogenesis of head and neck cancer. Mutat Res. 2011;716(1–2):51–8.CrossRefPubMed Sliwinski T, Markiewicz L, Rusin P, Kabzinski J, Dziki L, Milonski J, et al. Impaired nucleotide excision repair pathway as a possible factor in pathogenesis of head and neck cancer. Mutat Res. 2011;716(1–2):51–8.CrossRefPubMed
13.
go back to reference Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, Popanda O. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer. 2009;125:1431–9.CrossRefPubMed Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, Popanda O. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer. 2009;125:1431–9.CrossRefPubMed
14.
go back to reference Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao J, Cao W, et al. Polymorphism of xeroderma pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer. 2006;118:714–20.CrossRefPubMed Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao J, Cao W, et al. Polymorphism of xeroderma pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer. 2006;118:714–20.CrossRefPubMed
15.
go back to reference Larynx. In: Edge SB, Byrd DR, Compton CC, et al., eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010. pp. 57–62. Larynx. In: Edge SB, Byrd DR, Compton CC, et al., eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010. pp. 57–62.
16.
go back to reference Shannon M, Lamerdin JE, Richardson L, McCutchen-Maloney SL, Hwang MH, et al. Characterization of the mouse XPF DNA repair gene and differential expression during spermatogenesis. Genomics. 1999;62:427–35.CrossRefPubMed Shannon M, Lamerdin JE, Richardson L, McCutchen-Maloney SL, Hwang MH, et al. Characterization of the mouse XPF DNA repair gene and differential expression during spermatogenesis. Genomics. 1999;62:427–35.CrossRefPubMed
17.
go back to reference Jones AR, Bell-Horwath TR, Li G, Rollmann SM, Merino EJ. Novel oxidatively activated agents modify DNA and are enhanced by ercc1 silencing. Chem Res Toxicol. 2012;25:2542–52.CrossRefPubMedPubMedCentral Jones AR, Bell-Horwath TR, Li G, Rollmann SM, Merino EJ. Novel oxidatively activated agents modify DNA and are enhanced by ercc1 silencing. Chem Res Toxicol. 2012;25:2542–52.CrossRefPubMedPubMedCentral
18.
go back to reference Yin J, Vogel U, Ma Y, Wang H, Wang C, Liang D, et al. A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population. Lung Cancer. 2012;76:286–91.CrossRefPubMed Yin J, Vogel U, Ma Y, Wang H, Wang C, Liang D, et al. A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population. Lung Cancer. 2012;76:286–91.CrossRefPubMed
19.
go back to reference Zhang N, Lin LY, Zhu LL, Wu F, Wen H, Pan D, et al. ERCC1 polymorphisms and risk of adult glioma in a Chinese population: a hospital-based case–control study. Cancer Invest. 2012;30:199–202.CrossRefPubMed Zhang N, Lin LY, Zhu LL, Wu F, Wen H, Pan D, et al. ERCC1 polymorphisms and risk of adult glioma in a Chinese population: a hospital-based case–control study. Cancer Invest. 2012;30:199–202.CrossRefPubMed
20.
go back to reference Yang Z, Fang X, Pei X, Li H. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population. Genet Test Mol Biomark. 2013;17:700–6.CrossRef Yang Z, Fang X, Pei X, Li H. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population. Genet Test Mol Biomark. 2013;17:700–6.CrossRef
21.
go back to reference Chu H, Gu D, Xu M, Xu Z, Gong Y, Gong W, et al. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis. 2013;28(4):441–6.CrossRefPubMed Chu H, Gu D, Xu M, Xu Z, Gong Y, Gong W, et al. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis. 2013;28(4):441–6.CrossRefPubMed
22.
go back to reference Rumiato E, Cavallin F, Boldrin E, Cagol M, Alfieri R, Basso D, et al. ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. Pharmacogenet Genomics. 2013;23(11):597–604.CrossRefPubMed Rumiato E, Cavallin F, Boldrin E, Cagol M, Alfieri R, Basso D, et al. ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. Pharmacogenet Genomics. 2013;23(11):597–604.CrossRefPubMed
23.
go back to reference Le Page F, Kwoh EE, Avrutskaya A, Gentil A, Leadon SA, Sarasin A, et al. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell. 2000;101:159–71.CrossRefPubMed Le Page F, Kwoh EE, Avrutskaya A, Gentil A, Leadon SA, Sarasin A, et al. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell. 2000;101:159–71.CrossRefPubMed
24.
go back to reference Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci. 2007;4:59–71.CrossRefPubMedPubMedCentral Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci. 2007;4:59–71.CrossRefPubMedPubMedCentral
25.
go back to reference International Agency for Rescarch on Cancer, World Health Organization. Alcohol drinking. Lyon: World Health Organization, International Agency for Research on Cancer; 1988. p. 8. International Agency for Rescarch on Cancer, World Health Organization. Alcohol drinking. Lyon: World Health Organization, International Agency for Research on Cancer; 1988. p. 8.
Metadata
Title
Association of single nucleotide polymorphisms of nucleotide excision repair genes with laryngeal cancer risk and interaction with cigarette smoking and alcohol drinking
Authors
Xiaoyu Li
Jing Xu
Xinxin Yang
Yungang Wu
Baohua Cheng
Dongfeng Chen
Bo Bai
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1610-0

Other articles of this Issue 5/2014

Tumor Biology 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine